Axelyf was founded in Iceland in 2022 with the goal of harnessing health benefits of natural molecules through chemistry and delivery engineering.
Location: United States
Total raised: $2.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.08.2025 | Seed | $2.6M | - |
Mentions in press and media 2
| Date | Title | Description |
| 29.08.2025 | Axelyf Closes $2.6M Seed Financing | Axelyf, Inc., a Brookline, MA-based biotechnology company developing next-generation lipid nanoparticle (LNP) delivery systems for RNA therapeutics, closed a $2.6m seed funding. x Please enable JavaScript Video Player is loading.Play Video ... |
| - | Axelyf | “Axelyf ehf” |